The Bispecific T-Cell Engagers (BiTEs) recognize a TAA in cancer cells and, in parallel, recruit T-cells in the tumor area to kill the recognized cancer cells through perforins and granzymes [109]. The gene discussed is PRF1; the disease is cancer.